426 related articles for article (PubMed ID: 30380840)
1. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
[TBL] [Abstract][Full Text] [Related]
2. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
4. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
5. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
[TBL] [Abstract][Full Text] [Related]
6. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.).
Limsuwanchote S; Wungsintaweekul J; Keawpradub N; Putalun W; Morimoto S; Tanaka H
Forensic Sci Int; 2014 Nov; 244():70-7. PubMed ID: 25216455
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom.
Le D; Goggin MM; Janis GC
J Anal Toxicol; 2012; 36(9):616-25. PubMed ID: 23024321
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
[TBL] [Abstract][Full Text] [Related]
9. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
Warner ML; Kaufman NC; Grundmann O
Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
[TBL] [Abstract][Full Text] [Related]
11. Methyl ester and aromatic ether modification of mitragynine for generation of mitragynine-specific polyclonal antibodies.
Mustafa RR; Sukor R; Mohd Nor SM; Saari N
J Immunol Methods; 2022 Aug; 507():113291. PubMed ID: 35640723
[TBL] [Abstract][Full Text] [Related]
12. Identification of metabolites and potential biomarkers of kratom in urine.
Basiliere S; Kerrigan S
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
[TBL] [Abstract][Full Text] [Related]
13. Testing for Kratom alkaloids in fingernail clippings - not only mitragynine.
Ameline A; Gheddar L; Arbouche N; Blanchot A; Raul JS; Kintz P
J Pharm Biomed Anal; 2024 Jun; 243():116078. PubMed ID: 38489958
[TBL] [Abstract][Full Text] [Related]
14. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
15. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
[TBL] [Abstract][Full Text] [Related]
17. Update on the Pharmacology and Legal Status of Kratom.
Prozialeck WC
J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
[TBL] [Abstract][Full Text] [Related]
18. Kratom policy: The challenge of balancing therapeutic potential with public safety.
Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
